Related Experiment Video
Updated: May 26, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent
Shuang Wei1, Min Xiong, Da-qian Zhan
1Research Laboratory and Hepatic Surgical Center, Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie Fang Da Dao, Wuhan, China.
Abstract:
Ku80 is a component of the protein complex called DNA-dependent protein kinase, which is involved in DNA double-strand break repair and multiple other functions. Previous studies revealed that Ku80 haplo-insufficient and poly (adenosine diphosphate-ribose) polymerase-null transgenic mice developed hepatocellular carcinoma (HCC) at a high frequency. The role of Ku80 has never been investigated in human HCC. Ku80 expressions in HCC and adjacent liver tissue were investigated by using immunohistochemical staining and western blot. Ku80 was transfected into a Ku80-deficient HCC cell line SMMC7721 cells, and the growth features of the Ku80-expressing cells and vector-transfected cells were studied both in vitro and in vivo. Cell cycle analysis and RNA interference were employed to investigate the mechanisms underlying the growth regulation associated with Ku80 expression. Ku80 was found frequently downregulated in HCC compared with adjacent liver tissue. Ku80 downregulation was significantly correlated with elevated hepatitis B virus-DNA load and severity of liver cirrhosis. Overexpression of Ku80 in SMMC7721 cells significantly suppressed cell proliferation in vitro and in vivo. Ku80 overexpression caused S-phase cell cycle arrest and was associated with upregulation of p53 and p21(CIP1/WAF1), and the inhibition of p53 or p21(CIP1/WAF1) expression by RNA interference overcame the growth suppression and S-phase arrest in the Ku80-expressing cells. A novel mechanism was revealed that Ku80 functions as a tumor suppressor in HCC by inducing S-phase arrest through a p53-dependent pathway.
Insights
Ku80, a DNA repair protein, acts as a tumor suppressor in hepatocellular carcinoma (HCC). Its downregulation correlates with HCC progression, and restoring Ku80 inhibits cancer growth via a p53-dependent pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ku80 is a key component of the DNA-dependent protein kinase complex involved in DNA repair.
- Previous studies linked Ku80 deficiency to high rates of hepatocellular carcinoma (HCC) in mice.
- The role of Ku80 in human HCC remains uninvestigated.
Purpose of the Study:
- To investigate the expression and function of Ku80 in human HCC.
- To elucidate the mechanism by which Ku80 influences HCC cell proliferation.
Main Methods:
- Immunohistochemical staining and western blot to assess Ku80 expression in HCC tissues.
- In vitro and in vivo studies using Ku80-transfected HCC cell lines (SMMC7721).
- Cell cycle analysis and RNA interference to explore growth regulation mechanisms.
Main Results:
- Ku80 expression was frequently downregulated in HCC compared to adjacent liver tissue.
- Ku80 downregulation correlated significantly with hepatitis B virus-DNA load and liver cirrhosis severity.
- Overexpression of Ku80 suppressed HCC cell proliferation in vitro and in vivo, inducing S-phase arrest via p53 and p21(CIP1/WAF1) upregulation.
Conclusions:
- Ku80 functions as a tumor suppressor in human HCC.
- Ku80 suppresses HCC growth by inducing S-phase arrest through a p53-dependent pathway.
- Ku80 downregulation is a potential biomarker for HCC progression.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
